Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toxoplasma | 17 | 2021 | 116 | 3.420 |
Why?
|
| Toxoplasmosis | 11 | 2021 | 66 | 2.820 |
Why?
|
| Plasmodium falciparum | 12 | 2020 | 47 | 1.770 |
Why?
|
| Protozoan Vaccines | 3 | 2019 | 11 | 1.220 |
Why?
|
| Protozoan Proteins | 9 | 2018 | 73 | 1.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 583 | 1.040 |
Why?
|
| Vaccines, Subunit | 3 | 2020 | 55 | 0.880 |
Why?
|
| Antigens, Protozoan | 3 | 2020 | 21 | 0.790 |
Why?
|
| Antimalarials | 3 | 2019 | 20 | 0.770 |
Why?
|
| Epitopes | 1 | 2020 | 255 | 0.710 |
Why?
|
| Protozoan Infections | 1 | 2019 | 3 | 0.700 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2021 | 49 | 0.680 |
Why?
|
| Spermidine | 1 | 2019 | 9 | 0.670 |
Why?
|
| Spermine | 1 | 2019 | 21 | 0.670 |
Why?
|
| Polyamines | 1 | 2019 | 34 | 0.660 |
Why?
|
| Membrane Transport Proteins | 3 | 2010 | 169 | 0.620 |
Why?
|
| Purines | 3 | 2010 | 92 | 0.600 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 437 | 0.600 |
Why?
|
| Nanoparticles | 2 | 2020 | 162 | 0.590 |
Why?
|
| Centrosome | 1 | 2016 | 22 | 0.540 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 12 | 0.540 |
Why?
|
| Cell Division | 1 | 2016 | 696 | 0.480 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 385 | 0.460 |
Why?
|
| HLA-B7 Antigen | 3 | 2020 | 7 | 0.410 |
Why?
|
| Immunoglobulin G | 5 | 2021 | 466 | 0.410 |
Why?
|
| Antiprotozoal Agents | 3 | 2019 | 32 | 0.390 |
Why?
|
| Photosynthetic Reaction Center Complex Proteins | 2 | 2001 | 27 | 0.380 |
Why?
|
| Antibodies, Protozoan | 3 | 2021 | 42 | 0.360 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1568 | 0.360 |
Why?
|
| Cyanobacteria | 2 | 2001 | 111 | 0.350 |
Why?
|
| Point-of-Care Testing | 2 | 2021 | 25 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2016 | 88 | 0.350 |
Why?
|
| Malaria | 2 | 2019 | 23 | 0.340 |
Why?
|
| Biological Transport | 1 | 2008 | 399 | 0.300 |
Why?
|
| Erythrocytes | 5 | 2010 | 254 | 0.290 |
Why?
|
| Animals | 19 | 2020 | 27127 | 0.280 |
Why?
|
| Immunoglobulin M | 4 | 2021 | 163 | 0.280 |
Why?
|
| Morocco | 3 | 2021 | 16 | 0.260 |
Why?
|
| Mice | 8 | 2020 | 11682 | 0.240 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2015 | 20 | 0.230 |
Why?
|
| Cell Membrane | 1 | 2006 | 667 | 0.220 |
Why?
|
| Gene Deletion | 3 | 2016 | 341 | 0.210 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 64 | 0.210 |
Why?
|
| Light | 2 | 2001 | 292 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 3191 | 0.210 |
Why?
|
| Methyltransferases | 3 | 2008 | 191 | 0.200 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2019 | 5 | 0.200 |
Why?
|
| Photosystem I Protein Complex | 1 | 2001 | 11 | 0.200 |
Why?
|
| Adjuvants, Immunologic | 2 | 2020 | 167 | 0.200 |
Why?
|
| Host-Parasite Interactions | 2 | 2019 | 30 | 0.190 |
Why?
|
| Parasitemia | 2 | 2019 | 6 | 0.190 |
Why?
|
| Immunoassay | 2 | 2021 | 92 | 0.190 |
Why?
|
| HLA-A11 Antigen | 1 | 2020 | 2 | 0.190 |
Why?
|
| Interferon-gamma | 2 | 2014 | 450 | 0.190 |
Why?
|
| HLA-A2 Antigen | 1 | 2020 | 31 | 0.190 |
Why?
|
| Peptides | 3 | 2014 | 646 | 0.190 |
Why?
|
| Parasites | 1 | 2020 | 8 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2873 | 0.180 |
Why?
|
| Trypanosomiasis | 1 | 2019 | 1 | 0.180 |
Why?
|
| Trypanosoma | 1 | 2019 | 3 | 0.180 |
Why?
|
| Plasmodium | 1 | 2019 | 10 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2020 | 141 | 0.170 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 210 | 0.170 |
Why?
|
| Parasite Load | 1 | 2019 | 2 | 0.170 |
Why?
|
| Plasmodium yoelii | 1 | 2019 | 4 | 0.170 |
Why?
|
| Colombia | 1 | 2018 | 12 | 0.160 |
Why?
|
| France | 1 | 2018 | 47 | 0.160 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2018 | 16 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2018 | 44 | 0.160 |
Why?
|
| Enzymes | 1 | 2018 | 47 | 0.160 |
Why?
|
| Drug Synergism | 1 | 2019 | 305 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2331 | 0.160 |
Why?
|
| Genetic Complementation Test | 2 | 2016 | 97 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 740 | 0.150 |
Why?
|
| Public Health | 1 | 2018 | 135 | 0.150 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 40 | 0.140 |
Why?
|
| Candida | 1 | 2006 | 18 | 0.140 |
Why?
|
| Cross-Priming | 1 | 2016 | 48 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1154 | 0.140 |
Why?
|
| Models, Molecular | 3 | 2018 | 1293 | 0.140 |
Why?
|
| Quinolones | 1 | 2016 | 60 | 0.140 |
Why?
|
| Amino Acids | 1 | 2006 | 252 | 0.130 |
Why?
|
| Immunologic Memory | 1 | 2016 | 161 | 0.130 |
Why?
|
| Humans | 16 | 2021 | 88286 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2016 | 107 | 0.130 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.130 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 11 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 157 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 38 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1083 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 103 | 0.120 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 248 | 0.120 |
Why?
|
| Triclosan | 1 | 2013 | 10 | 0.110 |
Why?
|
| Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) | 1 | 2013 | 12 | 0.110 |
Why?
|
| United States | 4 | 2018 | 6857 | 0.110 |
Why?
|
| Spleen | 1 | 2014 | 431 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2015 | 469 | 0.110 |
Why?
|
| Morpholinos | 1 | 2012 | 13 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1423 | 0.100 |
Why?
|
| Culture Media | 2 | 2006 | 147 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 50 | 0.100 |
Why?
|
| Phosphatidylcholines | 2 | 2008 | 48 | 0.100 |
Why?
|
| Phycobilisomes | 2 | 2001 | 8 | 0.100 |
Why?
|
| Benzamides | 1 | 2012 | 239 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 686 | 0.090 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2010 | 2 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 956 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2019 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 645 | 0.090 |
Why?
|
| Female | 8 | 2021 | 45560 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2012 | 357 | 0.090 |
Why?
|
| Tubulin | 1 | 2010 | 58 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 803 | 0.090 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 379 | 0.090 |
Why?
|
| Xanthine | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 508 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 253 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 194 | 0.080 |
Why?
|
| Guanosine | 1 | 2008 | 30 | 0.080 |
Why?
|
| Adenine | 1 | 2008 | 88 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1638 | 0.080 |
Why?
|
| Boron Compounds | 1 | 2007 | 20 | 0.080 |
Why?
|
| Proteasome Inhibitors | 1 | 2007 | 52 | 0.080 |
Why?
|
| Boronic Acids | 1 | 2007 | 56 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 74 | 0.070 |
Why?
|
| Guanine | 1 | 2008 | 208 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 380 | 0.070 |
Why?
|
| HIV Infections | 1 | 2016 | 825 | 0.070 |
Why?
|
| Pyrazines | 1 | 2007 | 94 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2007 | 191 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2006 | 73 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 182 | 0.070 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 117 | 0.060 |
Why?
|
| Prevalence | 2 | 2021 | 1245 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 891 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 245 | 0.060 |
Why?
|
| Permeability | 2 | 2015 | 137 | 0.060 |
Why?
|
| Methylation | 3 | 2010 | 265 | 0.060 |
Why?
|
| Pregnancy | 2 | 2021 | 2986 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 2063 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2016 | 232 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 55 | 0.050 |
Why?
|
| Diuron | 1 | 2001 | 4 | 0.050 |
Why?
|
| Photosystem II Protein Complex | 1 | 2001 | 21 | 0.050 |
Why?
|
| Lighting | 1 | 2001 | 32 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2001 | 0.050 |
Why?
|
| Electron Transport | 1 | 2001 | 73 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Laboratories | 1 | 2021 | 44 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 76 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 71 | 0.050 |
Why?
|
| Thylakoids | 1 | 2000 | 10 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 73 | 0.050 |
Why?
|
| Fluorescence | 1 | 2000 | 102 | 0.040 |
Why?
|
| Phenotype | 1 | 2006 | 2430 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 306 | 0.040 |
Why?
|
| Malaria, Falciparum | 2 | 2010 | 12 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 319 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2012 | 754 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 400 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 66 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 5299 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 144 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 6171 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 486 | 0.040 |
Why?
|
| Serine | 2 | 2008 | 102 | 0.040 |
Why?
|
| Hyphae | 1 | 2006 | 7 | 0.040 |
Why?
|
| Developing Countries | 1 | 2017 | 74 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 62 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 155 | 0.040 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 6 | 0.040 |
Why?
|
| Cytochromes b | 1 | 2016 | 9 | 0.040 |
Why?
|
| Oocysts | 1 | 2016 | 7 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1943 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 9125 | 0.030 |
Why?
|
| Microscopy | 1 | 2006 | 88 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 305 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 2402 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 69 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 149 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2010 | 436 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 884 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 26230 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 15 | 0.030 |
Why?
|
| Occludin | 1 | 2015 | 66 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2006 | 205 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 81 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 326 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 276 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 283 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1846 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 123 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 463 | 0.030 |
Why?
|
| Apicomplexa | 1 | 2012 | 5 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 32 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 234 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 289 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 943 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 411 | 0.030 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2012 | 8 | 0.030 |
Why?
|
| Luciferases | 1 | 2012 | 128 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 144 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2012 | 22 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 152 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 18834 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1587 | 0.030 |
Why?
|
| Organelles | 1 | 2012 | 56 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2015 | 424 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5430 | 0.020 |
Why?
|
| Tetracyclines | 1 | 2010 | 4 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 135 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2629 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 379 | 0.020 |
Why?
|
| Floxuridine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 29 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 419 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 160 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 391 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 27 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 324 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25571 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1984 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 132 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 75 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 265 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 181 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3109 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2010 | 131 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 275 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 3667 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 797 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 353 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 272 | 0.020 |
Why?
|
| Ethanolamine | 1 | 2008 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 913 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 15 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2008 | 24 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 227 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2007 | 16 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 115 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 460 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 82 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 204 | 0.020 |
Why?
|
| DNA Replication | 1 | 2007 | 169 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1481 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 338 | 0.020 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2006 | 2 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 276 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 881 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 182 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 941 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1213 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3030 | 0.020 |
Why?
|
| Child | 1 | 2016 | 7074 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1213 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1639 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1972 | 0.010 |
Why?
|
| Male | 2 | 2016 | 41840 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 2257 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3358 | 0.010 |
Why?
|